Govender Ireshyn Selvan, Mokoena Rethabile, Stoychev Stoyan, Naicker Previn
NextGen Health, Council for Scientific and Industrial Research, Pretoria 0001, South Africa.
ReSyn Biosciences, Edenvale 1610, South Africa.
Proteomes. 2023 Sep 28;11(4):29. doi: 10.3390/proteomes11040029.
Urine provides a diverse source of information related to a patient's health status and is ideal for clinical proteomics due to its ease of collection. To date, most methods for the preparation of urine samples lack the throughput required to analyze large clinical cohorts. To this end, we developed a novel workflow, urine-HILIC (uHLC), based on an on-bead protein capture, clean-up, and digestion without the need for bottleneck processing steps such as protein precipitation or centrifugation. The workflow was applied to an acute kidney injury (AKI) pilot study. Urine from clinical samples and a pooled sample was subjected to automated sample preparation in a KingFisher™ Flex magnetic handling station using the novel approach based on MagReSyn HILIC microspheres. For benchmarking, the pooled sample was also prepared using a published protocol based on an on-membrane (OM) protein capture and digestion workflow. Peptides were analyzed by LCMS in data-independent acquisition (DIA) mode using a Dionex Ultimate 3000 UPLC coupled to a Sciex 5600 mass spectrometer. The data were searched in Spectronaut™ 17. Both workflows showed similar peptide and protein identifications in the pooled sample. The uHLC workflow was easier to set up and complete, having less hands-on time than the OM method, with fewer manual processing steps. Lower peptide and protein coefficient of variation was observed in the uHLC technical replicates. Following statistical analysis, candidate protein markers were filtered, at ≥8.35-fold change in abundance, ≥2 unique peptides and ≤1% false discovery rate, and revealed 121 significant, differentially abundant proteins, some of which have known associations with kidney injury. The pilot data derived using this novel workflow provide information on the urinary proteome of patients with AKI. Further exploration in a larger cohort using this novel high-throughput method is warranted.
尿液提供了与患者健康状况相关的多种信息来源,并且由于其易于收集,是临床蛋白质组学的理想样本。迄今为止,大多数尿液样本制备方法缺乏分析大型临床队列所需的通量。为此,我们基于磁珠上的蛋白质捕获、净化和消化,开发了一种新颖的工作流程——尿液亲水作用色谱法(uHLC),无需蛋白质沉淀或离心等瓶颈处理步骤。该工作流程应用于急性肾损伤(AKI)的初步研究。临床样本和混合样本的尿液在KingFisher™ Flex磁珠处理工作站中,使用基于MagReSyn亲水作用色谱微球的新方法进行自动样本制备。为了进行基准测试,混合样本也使用基于膜上(OM)蛋白质捕获和消化工作流程的已发表方案进行制备。肽段通过液相色谱-质谱联用仪(LCMS)在数据非依赖采集(DIA)模式下进行分析,使用Dionex Ultimate 3000超高效液相色谱仪与Sciex 5600质谱仪联用。数据在Spectronaut™ 17中进行搜索。两种工作流程在混合样本中显示出相似的肽段和蛋白质鉴定结果。uHLC工作流程更易于设置和完成,与OM方法相比,实际操作时间更少,手动处理步骤更少。在uHLC技术重复中观察到较低的肽段和蛋白质变异系数。经过统计分析,候选蛋白质标志物在丰度变化≥8.35倍、至少2个独特肽段且错误发现率≤1%的条件下进行筛选,共发现121种显著差异丰富的蛋白质,其中一些与肾损伤有已知关联。使用这种新颖工作流程获得的初步数据提供了急性肾损伤患者尿液蛋白质组的信息。有必要使用这种新颖的高通量方法在更大的队列中进行进一步探索。